J Yu
Jun 10, 2014
Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder
Hermanns T, Templeton A, Zlotta A, Fleshner N, Jewett M, Almatar A, Bhatt J, Richard P, Noon A, Yu J, Wei Y, Bhindi B, Kulkarni G. Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Br J Cancer 2014; 111:444-51.
Jun 10, 2014Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder
Jun 10, 2014Br J Cancer 2014; 111:444-51
Hermanns T, Templeton Arnoud, Zlotta A R, Fleshner N E, Jewett M A S, Almatar A, Bhatt J R, Richard P O, Noon A P, Yu J, Wei Y, Bhindi B, Kulkarni G S
more
Mar 1, 1998
Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit.
Yu J, Zhang Y, McIlroy J, Rordorf T, Orr G, Backer J. Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 1998; 18:1379-87.
Mar 1, 1998Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit.
Mar 1, 1998Mol Cell Biol 1998; 18:1379-87
Yu J, Zhang Yan, McIlroy J, Rordorf Tamara, Orr G A, Backer J M
more